In Vitro Transcription Factor Binding DAP-Seq Service: Antibody-Free Target Discovery

Q: What is the main advantage of DAP-Seq over ChIP-seq?

The absolute primary advantage is complete independence from antibodies. DAP-Seq completely eliminates the lengthy timeline, unpredictable costs, and high failure rates associated with generating custom antibodies for novel transcription factors. This makes it the vastly preferred, and sometimes only, method for plant biologists and researchers studying unique non-model organisms.

Q: How do you ensure the in vitro expressed TF maintains its natural folding and DNA-binding activity?

We utilize a specialized cell-free protein expression system (such as wheat germ extract) that provides the necessary eukaryotic chaperones and is highly efficient at properly folding complex proteins. Additionally, placing the HaloTag strategically ensures it does not physically block or hinder the critical DNA-binding domain. We strictly verify the protein's size and expression levels using Western blots prior to initiating the DNA binding step.

Q: Because DAP-Seq is performed in vitro on naked gDNA, how can I account for in vivo chromatin accessibility restrictions?

In vitro binding effectively reveals the protein's absolute, unrestricted sequence preference, regardless of whether that specific sequence is tightly wrapped around a nucleosome in a living cell. To filter out binding sites that are structurally inaccessible and functionally inactive in vivo, we strongly advise cross-referencing your DAP-Seq peaks with accessibility data or RNA-seq data (to verify which genes are actually undergoing changes in transcript abundance).

DNA Affinity Purification Sequencing (DAP-Seq) is an in vitro assay that identifies transcription factor binding sites across the entire genome. It solves a major research bottleneck: the lack of highly specific antibodies. By expressing your target protein in a cell-free system, our in vitro transcription factor binding DAP-Seq service maps complex regulatory networks directly, completely bypassing the need for ChIP-grade antibodies.

Key Service Advantages:

100% Antibody-Free Processing: Eliminates the exorbitant costs, extended timelines, and frequent failure risks associated with custom antibody generation.
Optimized Protein Expression: Utilizes a highly reliable HaloTag cell-free system to ensure proper protein folding and preserve natural DNA-binding activity.
Strict Quality Control Checkpoints: Mandatory Western blot verification confirms successful, full-length protein expression before any sequencing library preparation begins.
Publication-Ready Bioinformatics: Delivers comprehensive data packages including high-resolution peak calling, de novo motif discovery, and target gene annotation.

Get a Quote

Illustration of DAP-Seq combining cell-free protein expression with genomic DNA library screening

Overcoming Bottlenecks

Overcoming ChIP-seq Antibody Bottlenecks with DAP-Seq

For decades, determining the exact genomic loci where a transcription factor (TF) binds to DNA relied almost exclusively on chromatin immunoprecipitation (ChIP). However, that traditional method is fundamentally dependent on the availability of a highly specific, ChIP-grade antibody capable of recognizing the target protein in its native, cross-linked state. For many researchers—especially those studying agricultural crops, fungi, or non-model organisms—commercial antibodies simply do not exist. Attempting to create a custom antibody can take months, cost thousands of dollars, and frequently results in poor binding affinity or unacceptable cross-reactivity that generates high background noise.

According to published reviews on transcription factor binding methods, in vitro approaches serve as highly effective and robust alternatives when in vivo profiling is restricted by antibody availability. DAP-Seq systematically solves this persistent bottleneck by taking the core binding experiment out of the cell.

Instead of relying on unpredictable antibodies to pull down native proteins from complex cellular lysates, we synthesize your specific transcription factor in a controlled tube and attach a specialized chemical tag (HaloTag). We then mix this perfectly tagged protein with a fragmented genomic DNA library extracted directly from your sample organism. The transcription factor naturally finds and binds to its preferred target DNA sequences based on sequence affinity. We then isolate the tagged protein using magnetic beads and sequence the attached DNA. This elegant process provides the exact genomic binding locations without ever introducing the variability of an antibody.

Applications

Diverse Applications in Epigenetics Research

Because it fundamentally does not rely on species-specific antibodies or highly optimized tissue cross-linking protocols, DAP-Seq is a highly versatile and scalable tool. It allows researchers to quickly answer structural and functional questions across diverse biological fields where traditional epigenomic profiling was previously considered impossible:

Plant Genomics & Traits

Plant tissues are notoriously difficult to process for chromatin extraction due to thick cell walls, large vacuoles, and interfering secondary metabolites like polyphenols. Furthermore, high-quality antibodies for plant TFs are exceptionally rare. DAP-Seq has become the gold standard to map stress-response networks (such as drought or salinity tolerance), flowering pathways, and growth regulators in critical crops like soybean, maize, wheat, and rice.

Non-Model Organisms

For newly sequenced, rare, or genetically unique organisms, commercial antibodies are entirely unavailable. Generating custom antibodies for these unique species is an enormous gamble. DAP-Seq empowers researchers to immediately begin mapping complex regulatory networks and identifying master regulators using only the purified genomic DNA and the known genetic sequence of the transcription factor.

TF Family Screening

Because the initial protein expression is performed in vitro without needing live cell cultures or transgenic lines, researchers can efficiently and simultaneously test multiple transcription factors from the same protein family. By running them in parallel against the exact same genomic DNA library, researchers can rapidly identify subtle differences in binding motif preferences and target specificities.

Workflow

Comprehensive DAP-Seq Workflow & Protein Expression QC

A common and valid concern with in vitro assays is whether the synthesized protein maintains its correct structural conformation and actually works. Our workflow integrates strict quality control checkpoints to guarantee the transcription factor maintains its natural DNA-binding function.

Genomic DNA Library Preparation: We extract high-quality, high-molecular-weight genomic DNA from your target organism and fragment it. Specific sequencing adapters are attached to create a highly stable DNA library that represents the organism's entire accessible genome.
In Vitro Protein Expression (QC Checkpoint): Your transcription factor coding sequence is seamlessly cloned into a specialized expression vector containing a HaloTag. We express the fusion protein using an optimized cell-free system (e.g., wheat germ extract), which efficiently supports proper eukaryotic protein folding. QC Pass Criteria: We perform a Western Blot or SDS-PAGE to visually confirm that the full-length TF-HaloTag fusion protein was successfully expressed in sufficient quantities before proceeding.
DNA Affinity Purification: The successfully expressed transcription factor is immobilized on magnetic beads coated with a highly specific HaloTag ligand. The fragmented genomic DNA library is incubated with the bound beads, allowing the TF to naturally bind to its specific target sequences. Unbound, non-specific DNA is washed away, and the strongly bound target DNA fragments are carefully eluted.
High-Throughput Sequencing: The eluted DNA is PCR-amplified and sequenced on an Illumina high-throughput platform using standard paired-end reads to map the exact fragments captured by the TF.

Sample Requirements

Sample Requirements for Genomic DNA and TF Sequences

Initiating a DAP-Seq project requires a remarkably straightforward sample submission. We only need two components: the genomic DNA of the organism and the genetic sequence of your transcription factor. Please carefully review our Sample Preparation Guide for detailed extraction protocols to ensure high DNA integrity.

Sample Type	Recommended Input	Minimum Input	Preparation Method	Shipping
Genomic DNA (gDNA)	> 5 µg	2 µg	CTAB or column extraction, completely RNase-treated	Dry Ice
TF Coding Sequence	Plasmid (>1 µg) or Raw Sequence	Complete CDS	Ensure absolutely no stop codons before the fusion tag	Dry Ice (Plasmid) / Email (Sequence)

Bioinformatics

Publication-Ready Bioinformatics for TF Binding Networks

Identifying the captured DNA fragments is only the first step. Transforming those raw sequence reads into meaningful biological insights requires advanced computational expertise. Our dedicated bioinformatics team processes the sequencing data using robust statistical models to deliver clear, visual answers about where your protein binds and what biological processes it controls.

Standard Deliverables:

Data Filtering & High-Fidelity Alignment: We rigorously clean the raw reads by trimming adapter sequences and filtering out low-quality data. The clean reads are then mapped accurately to your provided reference genome using advanced short-read aligners.
Precision Peak Calling: We utilize established statistical models (like MACS2) to identify true binding regions (peaks) and separate them from random genomic background noise, assigning a statistical significance score to every binding event.
Genomic Annotation: We precisely map the identified peaks to specific gene regions. Our reports clearly show the percentage of your transcription factor binding to critical regulatory zones like promoters (TSS), upstream enhancers, introns, or distal intergenic regions.
De Novo Motif Discovery: We computationally analyze the exact DNA sequences underlying the strongest peaks to find the consensus pattern (motif) your transcription factor prefers to bind, offering deep mechanistic insights into its structural affinity.

Advanced Filtering Strategies:

Because DAP-Seq mixes pure proteins and naked DNA in a tube, the transcription factor might theoretically bind to DNA regions that are normally tightly wrapped in dense chromatin and entirely inaccessible inside a living cell. To filter out these potential in vitro false positives and identify biologically active targets, we highly recommend Integrating RNA-seq and Epigenomic Data Analysis.

By computationally cross-referencing your DAP-Seq binding loci with actual gene expression changes (fold-change values) from your RNA-seq datasets, you can definitively confirm which binding events actively turn specific genes on or off in reality. Such multi-omics correlation is crucial for building robust, defensible regulatory networks.

Demo Results

Demo Results: Visualizing Your TF Targets and Motifs

Our data reports are meticulously designed so that the provided figures can be directly exported into your manuscript or grant presentation without requiring additional formatting.

Protein Expression QC Image: A clear, high-contrast Western blot image verifying the successful synthesis and correct molecular weight of your specific TF-HaloTag fusion protein.
IGV Browser Tracks: A highly visual map showing exactly where the sequence reads pile up to form distinct peaks over specific gene bodies and promoters in the reference genome, confirming binding specificity.
Sequence Motif Logo: A visual graphic representing the consensus binding motif. The height of each nucleotide letter indicates how strongly the transcription factor prefers that specific DNA base at that position.
Genomic Distribution Pie Chart: A simple, quantitative chart illustrating the global distribution of binding sites, revealing whether the TF acts primarily at proximal promoters or distal enhancers.
Target Gene Functional Enrichment: Advanced scatter plots grouping the hundreds of identified downstream target genes into known Gene Ontology (GO) biological pathways, helping to rapidly explain the transcription factor's overall cellular function.

Technology Selection

Technology Selection: DAP-Seq vs. ChIP-seq vs. CUT&Tag

Deciding which epigenomic method to use depends entirely on your antibody availability, cell number, and the specific biological question you need to answer. Use the comprehensive guide below to evaluate your options.

Dimension	DAP-Seq	ChIP-seq	CUT&Tag
Antibody Requirement	None (Utilizes a universal HaloTag fusion system)	High (Requires a highly specific, ChIP-grade antibody)	High (Requires a highly specific, sensitive antibody)
Binding Context	In vitro (Naked genomic DNA library)	In vivo (Native, cross-linked chromatin)	In vivo (Native, intact chromatin)
Input Material Required	Purified gDNA + TF Sequence	Millions of cross-linked cells per reaction	Around 100,000 live or frozen cells
Best Used For	Plants, fungi, and non-model organisms lacking specific antibodies.	Standard model organisms with highly validated, commercial antibodies.	Standard model organisms with severely limited cell numbers or rare populations.

Selection Strategy:

Choose DAP-Seq if you are working with a unique organism or a novel transcription factor where reliable, non-cross-reactive antibodies simply do not exist.
Choose ChIP-seq Services if you already possess a highly validated antibody and need to capture the true in vivo binding context, accounting for the natural physical restrictions of local chromatin structure.
Choose CUT&RUN Services or CUT&Tag if you have a good antibody but are working with a very low number of cells, such as sorted stem cells or rare clinical biopsies.
Choose ATAC-seq Services if you do not have a specific target protein in mind, but instead want an unbiased map of all open chromatin regions across the entire genome.
Choose WGBS Services if your research focuses on mapping DNA methylation modifications rather than transcription factor binding events.

Case Study

Client Success Case Study: Uncovering Soybean Leaflet Modulators via DAP-Seq

Uncovering Soybean Leaflet Modulators via DAP-Seq

To demonstrate the immense practical value of DAP-Seq in high-stakes agricultural research, we highlight a recently published paper from one of our clients investigating critical elements of plant morphology.

Research Background: Soybean leaf shape and leaflet number directly impact photosynthetic efficiency, light canopy penetration, and ultimately, total crop yield. The client's research team successfully identified Lf2, a knotted homeobox transcription factor, as a master regulator of this process. Because specific, high-affinity antibodies for the unique soybean Lf2 protein were entirely unavailable on the commercial market, performing traditional ChIP-seq to find its downstream target genes was impossible.

Methods: The client utilized our comprehensive DAP-Seq service to bypass this bottleneck. We successfully synthesized the soybean Lf2 protein in vitro using our optimized HaloTag fusion expression system. We then incubated this biologically active protein with a highly complex, fragmented genomic DNA library prepared directly from soybean leaves. Following strict affinity purification protocols, the bound DNA fragments were isolated and subjected to high-throughput sequencing.

Results: The DAP-Seq data successfully and robustly captured the genome-wide binding sites for the Lf2 transcription factor. As detailed in Figure 4 of the published study, our bioinformatics pipeline identified a highly specific consensus binding motif. Furthermore, the binding peak data definitively confirmed that Lf2 directly binds to the promoter regions of several key downstream genes heavily involved in regulating leaflet development and cellular proliferation.

Conclusion: By leveraging our antibody-free in vitro approach, the client successfully bypassed the severe limitations of plant epigenomic research. The high-quality data provided the direct, physical evidence needed to map the complex Lf2 regulatory network, fundamentally supporting their prestigious publication in The Plant Journal.

FAQ

Frequently Asked Questions (FAQ)

1. What is the main advantage of DAP-Seq over ChIP-seq?

2. How do you ensure the in vitro expressed TF maintains its natural folding and DNA-binding activity?

3. Because DAP-Seq is performed in vitro on naked gDNA, how can I account for in vivo chromatin accessibility restrictions?

In vitro binding effectively reveals the protein's absolute, unrestricted sequence preference, regardless of whether that specific sequence is tightly wrapped around a nucleosome in a living cell. To filter out binding sites that are structurally inaccessible and functionally inactive in vivo, we strongly advise cross-referencing your DAP-Seq peaks with accessibility data or RNA-seq data (to verify which genes are actually undergoing changes in transcript abundance).

References

Disclaimer: Research Use Only (RUO). All services, protocols, and data analysis provided by CD Genomics are intended strictly for basic research and discovery purposes. They are not intended, nor validated, for use in diagnostic, therapeutic, or clinical applications.

! For research purposes only. Not intended for clinical diagnosis, treatment, or individual health assessments.